PAIN
Volume 147, Issue 1 , Pages 36-45 , 15 December 2009

The analgesic action of topical diclofenac may be mediated through peripheral NMDA receptor antagonism

  • Xu-Dong Dong

      Affiliations

    • Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada V6T 1Z3
    • ,
  • Peter Svensson

      Affiliations

    • Department of Clinical Oral Physiology, School of Dentistry, Faculty of Health Sciences, University of Aarhus, DK-8000 Aarhus C, Denmark
    • ,
  • Brian E. Cairns

      Affiliations

    • Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada V6T 1Z3
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 822 7715; fax: +1 604 822 3035.

Received 16 March 2009 ,Revised 12 June 2009 ,Accepted 22 July 2009.

References 

  1. Acosta MC, Berenguer-Ruiz L, García-Gálvez A, Perea-Tortosa D, Gallar J, Belmonte C. Changes in mechanical, chemical, and thermal sensitivity of the cornea after topical application of nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci. 2005;46:282–286
  2. Acosta MC, Luna C, Graff G, Meseguer VM, Viana F, Gallar J, et al. Comparative effects of the nonsteroidal anti-inflammatory drug nepafenac on corneal sensory nerve fibers responding to chemical irritation. Invest Ophthalmol Vis Sci. 2007;48:182–188
  3. Affaitati G, Vecchiet F, Lerza R, De Laurentis S, Iezzi S, Festa F, et al. Effects of topical diclofenac (DHEP plaster) on skin, subcutis and muscle pain thresholds in subjects without spontaneous pain. Drugs Exp Clin Res. 2001;27:69–76
  4. Alfredson H, Ljung BO, Thorsen K, Lorentzon RJ. In vivo investigation of ECRB tendons with microdialysis technique – no signs of inflammation but high amounts of glutamate in tennis elbow. Acta Orthop Scand. 2000;71:475–479
  5. Alfredson H, Forsgren S, Thorsen K, Lorentzon RJ. In vivo microdialysis and immunohistochemical analyses of tendon tissue demonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper’s knee. Orthop Res. 2001;19:881–886
  6. Alfredson H, Lorentzon RJ. Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?. Curr Drug Targets. 2002;3:43–54
  7. Alves DP, Tatsuo MA, Leite R, Duarte ID. Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activation. Life Sci. 2004;74:2577–2591
  8. Blanco FJ, Guitian R, Moreno J, de Toro FJ, Galdo F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol. 1999;26:1366–1373
  9. Cairns BE, Gambarota G, Svensson P, Arendt-Nielsen L, Berde CB. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience. 2002;109:389–399
  10. Cairns BE, Gambarota G, Dunning PS, Mulkern RV, Berde CB. Activation of peripheral excitatory amino acid receptors decreases the duration of local anesthesia. Anesthesiology. 2003;98:521–529
  11. Cairns BE, Svensson P, Wang K, Hupfeld S, Graven-Nielsen T, Sessle BJ, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 2003;90:2098–2105
  12. Cairns BE, Dong X, Mann MK, Svensson P, Sessle BJ, Arendt-Nielsen L, et al. Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers. Pain. 2007;132:33–41
  13. Cairns BE, Dong XD. The role of peripheral glutamate and glutamate receptors in muscle pain. J Musculoskeletal Pain. 2008;16:85–91
  14. Cairns BE, Mann MK, Mok E, Dong XD, Svensson P. Diclofenac exerts local anesthetic-like actions on rat masseter muscle afferent fibers. Brain Res. 2008;1194:56–64
  15. Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996;52:13–23
  16. Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochimica et Biophysica Acta. 2001;1514:191–205
  17. Chen X, Gallar J, Belmonte C. Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation. Invest Ophthalmol Vis Sci. 1997;38:1944–1953
  18. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104:413–421
  19. Di Rienzo Businco L, Di Rienzo Businco A, D’Emilia M, Lauriello M, Coen Tirelli G. Topical versus systemic diclofenac in the treatment of temporomandibular joint dysfunction symptoms. Acta Otorhinolaryngol Ital. 2004;24:279–285
  20. Dina OA, Green PG, Levine JD. Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience. 2008;152:521–525
  21. Dina OA, Levine JD, Green PG. Muscle inflammation induces a protein kinase Cepsilon-dependent chronic-latent muscle pain. J Pain. 2008;9:457–462
  22. Dong XD, Mann MK, Kumar U, Svensson P, Arendt-Nielsen L, Hu JW, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge result from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience. 2007;146:822–832
  23. Edwards SR, Mather LE, Lin Y, Power I, Cousins MJ. Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac. J Pharm Pharmacol. 2000;52:59–66
  24. Edwards SR, Mather LE. editors. Kynurenate: A factor in the analgetic action of NSAIDs? Abstracts: 10th World Congress on Pain. Seattle: IASP Press; 2002. p. 281–2.
  25. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp S. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci. 1999;65:313–325
  26. Ernberg M, Lundeberg T, Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain. 2000;85:31–39
  27. Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain. 2000;84:339–346
  28. Ernberg M, Lundeberg T, Kopp S. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia. Pain. 2003;101:275–282
  29. Galer BS, Rowbotham M, Perander J, Devers A, Friedman E. Topical diclofenac patch relieves minor sports injury pain: results of a multicenter controlled clinical trial. J Pain Symptom Manage. 2000;19:287–294
  30. Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Clin Pharmacol Ther. 2002;72:175–183
  31. Gotzsche PC. Non-steroidal anti-inflammatory drugs. BMJ. 2000;320:1063–1070
  32. Graven-Nielsen T, Mense S. The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain. 2001;17:2–10
  33. Hedenberg-Magnusson B, Ernberg M, Alstergren P, Kopp S. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Odontol Scand. 2001;59:348–355
  34. Kuo CC, Huang RC, Lou BS. Inhibition of Na(+) current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels. Mol Pharmacol. 2000;57:135–143
  35. McQuay HJ, Moore RA. Side effects of COX-2 inhibitors and other NSAIDs. In:  Koltzenburg M editors. Proceedings of the 10th World Congress on Pain. Vol. 24:Seattle: IASP press; 2003;p. 499–510
  36. McRoberts JA, Coutinho SV, Marvizon JC, Grady EF, Tognetto M, Sengupta JN, et al. Role of peripheral N-methyl-d-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology. 2001;120:1737–1748
  37. Mense S. Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2. Brain Res. 1981;225:95–105
  38. Mok E, Mann MK, Dong XD, Cairns BE. Local anaesthetic-like effects of diclofenac on muscle nociceptors. Pain Res Manage. 2005;10:95
  39. Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316:333–338
  40. Mørk H, Ashina M, Bendtsen L, Olesen J, Jensen R. Experimental muscle pain and tenderness following infusion of endogenous substances in humans. Eur J Pain. 2003;7:145–153
  41. Ortiz MI, Torres-Lopez JE, Castaneda-Hernandez G, Rosas R, Vidal-Cantu GC, Granados-Soto V. Pharmacological evidence for the activation of K(+) channels by diclofenac. Eur J Pharmacol. 2002;438:85–91
  42. Rosendal L, Larsson B, Kristiansen J, Peolsson M, Søgaard K, Kjær M, et al. Increase in muscle nociceptive substances and anaerobic metabolism in patients with trapezius myalgia: microdialysis in rest and during exercise. Pain. 2004;112:324–334
  43. Schaible HG, Schmidt RF. Excitation and sensitization of fine articular afferents from cat’s knee joint by prostaglandin E2. J Physiol. 1988;403:91–104
  44. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002;966:343–354
  45. Schepelmann K, Messlinger K, Schaible HG, Schmidt RF. Inflammatory mediators and nociception in the joint: excitation and sensitization of slowly conducting afferent fibers of cat’s knee by prostaglandin I2. Neuroscience. 1992;50:237–247
  46. Sotgiu ML, Biella G, Formaglio F, Marchettini P. Central effect of ketorolac involving NMDA receptors activity. Brain Res. 1998;813:223–226
  47. Sung D, Dong X, Ernberg M, Kumar U, Cairns BE. Serotonin (5-HT) excites rat masticatory muscle afferent fibers through activation of peripheral 5-HT3 receptors. Pain. 2008;134:41–50
  48. Svensson P, Cairns BE, Wang K, Hu JW, Graven-Nielsen T, Arendt-Nielsen L, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain. 2003;101:221–227
  49. Tegeder L, Zimmermann J, Meller ST, Geisslinger G. Release of algesic substances in human experimental muscle pain. Inflamm Res. 2002;51:393–402
  50. Vaile JH, Davis P. Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs. 1998;56:783–799
  51. Walker JS. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol. 1995;22:855–860
  52. Weber M, Dietrich D, Gräsel I, Reuter G, Seifert G, Steinhäuser C. 6-Hydroxykynurenic acid and kynurenic acid differently antagonise AMPA and NMDA receptors in hippocampal neurons. J Neurochem. 2001;77:1108–1115
  53. Zacher J, Altman R, Bellamy c, P. Brühlmann N, Da Silva J, Huskisson E, Taylor RS. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 2008;24:925–50.

PII: S0304-3959(09)00415-1

doi: 10.1016/j.pain.2009.07.031

PAIN
Volume 147, Issue 1 , Pages 36-45 , 15 December 2009

Article Tools

* Image Usage & Resolution